Amarin Corporation PLC/UK - Ordinary Shares, par value 50 pence per share (AMRN)

CUSIP: 023111206

Q4 2024 13F Holders as of 31 Dec 2024

Holder snapshot 7 signals
Share change
+5,183,812
Put/Call ratio
37%
SEC-reported price per share
$0.48
Number of holders
157
Value change
+$2,459,088
Number of buys
48
Open additional details 1 more signal available
Number of sells
64
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
422,724,138

Security key

023111206

Report period

Q4 2024

Institutions

157

Top holders

10

Ownership snapshot

Top reported holders of AMRN - Amarin Corporation PLC/UK - Ordinary Shares, par value 50 pence per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Sarissa Capital Managemen...
Disclosed value leader
Sarissa Capital Managemen...
Comparable rows
0/15
Latest evidence
30 Sep 2024
13F 3/4/5 Highest disclosed value: $15,578,856 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Sarissa Capital Management LP has the largest disclosed position value at $15.58M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Sarissa Capital Management LP's linked filing trail.
Disclosed position value Top 5
Sarissa Capital Management LP $15.58M
Kynam Capital Management, LP $7.78M
John F. Thero $3.55M
Eversept Partners, LP $2.07M
MORGAN STANLEY $1.6M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Sarissa Capital Management LP
13F
Company
13F
—
denominator unverified
$15,578,856
24,850,623 shares
— 30 Sep 2024
Kynam Capital Management, LP
13F
Company
13F
—
denominator unverified
$7,782,730
12,414,628 shares
— 30 Sep 2024
John F. Thero
3/4/5
President and CEO, Director
—
mixed-class rows
$3,545,500
3,266,224 shares
mixed-class rows
— 30 Jul 2021
Eversept Partners, LP
13F
Company
13F
—
denominator unverified
$2,074,606
3,309,309 shares
— 30 Sep 2024
MORGAN STANLEY
13F
Company
13F
—
denominator unverified
$1,595,932
2,545,752 shares
— 30 Sep 2024
SCP Investment, LP
13F
Company
13F
—
denominator unverified
$1,567,250
2,500,000 shares
— 30 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
157
Shares
70,860,688
Rows available
157
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2024 vs Q1 2026 Across Filers

Q1 2026 holders
2
Q4 2024 holders
157
Holder diff
155
Investor Q1 2026 Shares Q4 2024 Shares Share Diff Share Chg % Q1 2026 value Q4 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .